OBI Medical
OBI Medical receives DKK 2.1 million in public funding from the Market Development Fund

OBI Medical is pleased to announce that the company has received DKK 2.1 million in public funding from Markedsmodningsfonden (in English ’The Market Development Fund’) to support the roll-out of the v-TAC solution into various clinical applications, including NIV treatment and adjustment of oxygen therapy of COPD patients, and screening of acute ill patients in emergency/acute departments. Throughout the project, OBI Medical will work closely with hospitals to collect experiences and ensure a seamless and efficient commissioning and daily use of the solution.

Read the full announcement from Markedsmodningsfonden here: